A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To obtain preliminary evidence of antiretroviral activity of 1592U89 when administered in
combination with other specific NRTI agents in NRTI experienced patients and to assess the
safety and tolerance of multiple oral doses of 1592U89 when administered in combination with
specific marketed NRTIs.